406 related articles for article (PubMed ID: 30930259)
1. Disparities and reverse disparities in HPV vaccination: A systematic review and meta-analysis.
Spencer JC; Calo WA; Brewer NT
Prev Med; 2019 Jun; 123():197-203. PubMed ID: 30930259
[TBL] [Abstract][Full Text] [Related]
2. Race-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress?
Burdette AM; Webb NS; Hill TD; Jokinen-Gordon H
Public Health; 2017 Jan; 142():167-176. PubMed ID: 27592005
[TBL] [Abstract][Full Text] [Related]
3. Disparities in awareness of the HPV vaccine and HPV-associated cancers among racial/ethnic minority populations: 2018 HINTS.
Le D; Kim HJ; Wen KY; Juon HS
Ethn Health; 2023 May; 28(4):586-600. PubMed ID: 36045478
[TBL] [Abstract][Full Text] [Related]
4. Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.
Landis K; Bednarczyk RA; Gaydos LM
Vaccine; 2018 Jun; 36(24):3498-3504. PubMed ID: 29752025
[TBL] [Abstract][Full Text] [Related]
5. Barriers to Human Papillomavirus Vaccine Uptake Among Racial/Ethnic Minorities: a Systematic Review.
Amboree TL; Darkoh C
J Racial Ethn Health Disparities; 2021 Oct; 8(5):1192-1207. PubMed ID: 33025422
[TBL] [Abstract][Full Text] [Related]
6. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.
Jeudin P; Liveright E; Del Carmen MG; Perkins RB
Clin Ther; 2014 Jan; 36(1):24-37. PubMed ID: 24417783
[TBL] [Abstract][Full Text] [Related]
7. Intersectional nativity and racial/ethnic disparities in human papillomavirus vaccination initiation among U.S. women: a national population-based study.
Agénor M; Abboud S; Delgadillo JG; Pérez AE; Peitzmeier SM; Borrero S
Cancer Causes Control; 2018 Oct; 29(10):927-936. PubMed ID: 30120642
[TBL] [Abstract][Full Text] [Related]
8. Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines.
Burger EA; Lee K; Saraiya M; Thompson TD; Chesson HW; Markowitz LE; Kim JJ
Cancer; 2016 Jul; 122(13):2057-66. PubMed ID: 27124396
[TBL] [Abstract][Full Text] [Related]
9. Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.
Adjei Boakye E; Tobo BB; Rojek RP; Mohammed KA; Geneus CJ; Osazuwa-Peters N
Hum Vaccin Immunother; 2017 Nov; 13(11):2713-2722. PubMed ID: 28853980
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus (HPV) vaccine initiation in minority Americans.
De P; Budhwani H
Public Health; 2017 Mar; 144():86-91. PubMed ID: 28274389
[TBL] [Abstract][Full Text] [Related]
11. Lower human papillomavirus vaccine initiation and completion among Asian American adolescents compared to their peers: National Health and Nutritional Examination Survey 2011-2018.
Zhao R; Prizment A; Kulasingam S
Cancer Causes Control; 2023 Jun; 34(6):543-552. PubMed ID: 36973601
[TBL] [Abstract][Full Text] [Related]
12. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.
Ylitalo KR; Lee H; Mehta NK
Am J Public Health; 2013 Jan; 103(1):164-9. PubMed ID: 22698055
[TBL] [Abstract][Full Text] [Related]
13. A multilevel analysis of factors influencing the inaccuracy of parental reports of adolescent HPV vaccination status.
Vu M; Luu M; Haardörfer R; Berg CJ; Escoffery C; Bednarczyk RA
Vaccine; 2019 Feb; 37(6):869-876. PubMed ID: 30626532
[TBL] [Abstract][Full Text] [Related]
14. Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory.
Polonijo AN; Carpiano RM
Soc Sci Med; 2013 Apr; 82():115-25. PubMed ID: 23337830
[TBL] [Abstract][Full Text] [Related]
15. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
[TBL] [Abstract][Full Text] [Related]
16. Unequal interactions: Examining the role of patient-centered care in reducing inequitable diffusion of a medical innovation, the human papillomavirus (HPV) vaccine.
Fenton AT; Elliott MN; Schwebel DC; Berkowitz Z; Liddon NC; Tortolero SR; Cuccaro PM; Davies SL; Schuster MA
Soc Sci Med; 2018 Mar; 200():238-248. PubMed ID: 29157686
[TBL] [Abstract][Full Text] [Related]
17. Race, Nativity, and Sex Disparities in Human Papillomavirus Vaccination Among Young Adults in the USA.
McElfish PA; Narcisse MR; Felix HC; Cascante DC; Nagarsheth N; Teeter B; Faramawi MF
J Racial Ethn Health Disparities; 2021 Oct; 8(5):1260-1266. PubMed ID: 33033889
[TBL] [Abstract][Full Text] [Related]
18. Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years.
Rincon NL; McDowell KR; Weatherspoon D; Ritchwood TD; Rocke DJ; Adjei Boakye E; Osazuwa-Peters N
Hum Vaccin Immunother; 2024 Dec; 20(1):2313249. PubMed ID: 38538572
[TBL] [Abstract][Full Text] [Related]
19. Racial/Ethnic Disparities in HPV Vaccine Uptake Among a Sample of College Women.
Okafor C; Hu X; Cook RL
J Racial Ethn Health Disparities; 2015 Sep; 2(3):311-6. PubMed ID: 26863461
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in human papillomavirus vaccination: does access matter?
Gelman A; Miller E; Schwarz EB; Akers AY; Jeong K; Borrero S
J Adolesc Health; 2013 Dec; 53(6):756-62. PubMed ID: 23992645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
